StockWatch: FDA Panel Enables Accelerated OK for Biogen ALS Drug
Mixed votes from an FDA advisory panel may help Biogen secure accelerated approval of ALS drug tofersen, licensed from Ionis Pharmaceuticals.
Source: genengnews.com
📰 Eunk Yang News
Eunk Yang News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Eunk Yang. Real-time updates on events, politics, business and more.
Albireo Pharma, Inc. (ALBO) Q1 2021 Earnings Call Transcript
Operator Good day and welcome to the alboreto pharma first quarter 2021 earnings conference call. [Operator Instructions] At this time, I would like to turn the conference over to Mr. Paul. Please go ahead, sir. Paul S. Bavier -- Interim President, General Counsel And Secretary Thank you, operator and good morning everyone. Thank you for joining todays call. This morning, Alberto issued a press release highlighting its recent business accomplishments and reporting its financial results for the...
Source: fool.com
AstraZeneca to Acquire Alexion for $39B, Adding Rare Disease, Immunology Assets
AstraZeneca to Acquire Alexion for $39B, Adding Rare Disease, Immunology Assets AstraZeneca signaled its intent to expand into rare disease drug development and grow into an immunology leader by announcing plans to acquire Alexion Pharmaceuticals for $39 billion, in what would be the largest biopharma acquisition of 2020.[Alexion Pharmaceuticals] December 14, 2020 AstraZeneca signaled its intent to expand into rare disease drug development and grow into an immunology leader by announcing plans...
Source: genengnews.com